Prostate Cancer
Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer - Abstract
November 22, 2011
Type of transrectal ultrasonography probe influences prostate cancer detection rates on repeat prostate biopsy - Abstract
November 22, 2011
Which patients are at the highest risk of dying from competing causes ≤10 years after radical prostatectomy? - Abstract
November 22, 2011
Role of lymphadenectomy for prostate cancer: Indications and controversies - Abstract
November 22, 2011
Personalized approach to prostate cancer prognosis - Abstract
November 22, 2011
High-risk prostate cancer: Value of multi-modality 3T MRI-guided biopsies after previous negative biopsies - Abstract
November 21, 2011
Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead - Abstract
November 21, 2011
Effect of constipation on serum total prostate-specific antigen levels in men - Abstract
November 21, 2011
Modifiable prostate cancer risk reduction and early detection behaviors in black men - Abstract
November 21, 2011
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC) - Abstract
November 18, 2011
Focal cryotherapy for localized prostate cancer: A report from the national Cryo On-Line Database (COLD) Registry - Abstract
November 18, 2011
Prostate-cancer screening - what the U.S. Preventive Services Task Force left out - Abstract
November 18, 2011
One man at a time - resolving the PSA controversy - Abstract
November 18, 2011
Defining and predicting indolent and low risk prostate cancer - Abstract
November 18, 2011